Tympanostomy Products Market - Size, Share, Outlook, and Opportunity Analysis, 2019

Tympanostomy is a surgical approach for the diagnosis and treatment of the ear infection. The procedures are carried out with the tubes, which are surgically implanted into the eardrum to promote drainage of infected fluid from the middle ear. The rising cases of ear infections worldwide, especially, among children is boosting the market growth. According to an article published in the National Center for Biotechnology Information (NCBI), November 2020, around 80% of children across the globe would experience otitis media during their lifetime, and between 80% and 90% of all children would experience otitis media with an effusion before school age.

Market Dynamics

Increasing number of ear infection cases is expected to drive growth of this market. For instance, according to an article published in the National Center for Biotechnology Information (NCBI), December 2017, the prevalence of middle ear infections was 5.8%, of which 4% had chronic suppurative otitis media in Rwanda. Moreover, according to an article published by the Lucile Packard Children’s Hospital at Stanford, in November 2017, middle ear infections occurred in 80% of children by the time they reached age 3.

Furthermore, key players in the market are involved in developing novel tympanostomy products. The approval and launch of such advanced devices in the market is expected to significantly drive the market growth and create conducive environment for tympanostomy products market over the forecast period. For instance, in June 2020, Preceptis Medical, Inc., the U.S.-based medical equipment manufacturer, received the U.S. Food and Drug Administration (FDA) 510(k) clearance for Hummingbird, a tympanostomy tube system. This system is a novel tool that reduces trauma and procedure time for ear tube placement. It also allows ear, nose & throat (ENT) surgeons to perform ear tube procedures (tympanostomy) in young children without general anesthesia. Similarly, in September 2016, Acclarent, Inc., a part of Johnson & Johnson Services Inc. that focuses on designing, developing, and commercializing medical devices for ear, nose and throat, launched ACCLARENT AERA, an eustachian tube balloon dilation system.

Key features of the study:

This report provides in-depth analysis of the global tympanostomy products market value, and provides market size (US$ 99.10 Mn) in 2020 and compound annual growth rate (CAGR 3.4%) for the forecast period (2020-2027), considering 2019 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global tympanostomy products market based on the following parameters – company overview, financial performance, device portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Medtronic Plc., Olympus Corporation, Medasil Surgical Limited, PreceptisMedical, Acclarent Inc., Summit Medical, Adept Medical, Teleflex Medical Ltd, and AdventaMed
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future device launches, market expansion, and marketing tactics
The global tympanostomy products market report caters to various stakeholders in this industry including investors, suppliers, device manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tympanostomy products market

Detailed Segmentation:

Global Tympanostomy Products Market , By Product Type :